Opening book details…
About this Medicine article
Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase: A Twenty-Eight–Day, Multicenter, Phase II, Randomized, Double-blind, Placebocontrolled, Dose-Response Clinical Trial Examining Safety and Efficacy in Patients With Gout by Pillinger, M.H. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Pillinger, M.H.
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV (ISSN 0084-3873)
- Published
- 2006
- Language
- EN
- Field
- Medicine (Health Sciences)